Summary:
UK developer of reusable, antiviral cloth face covering/snood with protective protein coating offers the product to small-large/multinational distributors as part of a distribution service agreement. The reusable face covering offers two-way protection against the transmission of viral infections, droplets, and aerosols in the form of a comfortable cloth snood. Expressions of interest from distribution companies across all partner countries are welcomed – except for Spain, New Zealand, and USA.
Description:
This UK SME, based in North Wales, specialises in the design and supply of reusable, antiviral cloth face coverings/snoods to a range of business to business (B2B) and business to consumer (B2C) customers. The product results from 10 years of research and development by a team of scientists and virologists. The team were successful in developing and mass manufacturing the protective snood at the start of the year and have saturated the immediate UK market due to the outbreak of COVID-19.
The product on offer is a reusable, single layer face covering made from a trademarked, antiviral textile capable of blocking and reducing the transmission of viral particles and infections. The textile offers antiviral protection in the form of a soft, cloth snood which has been tested and certified to ISO18184:2019. The snood offers a comfortable alternative to disposable and homemade/fashion masks which do not provide specific antiviral protection.
The client therefore seeks a distribution service agreement from small to multinational sized distribution companies in all partner countries, with the exception of Spain, New Zealand, and the United States of America. Such partners are sought to engage in a distribution agreement because the client wishes to enter new retail markets and increase overseas trade.
Potential partners are expected to have knowledge and routes into regional/national retail markets and existing relations or access to various buyers i.e. wholesalers, end-user retailers, or other retail industry organisations.
The client hopes to successfully integrate the product across international retail markets, significantly increase overseas trade, and enhance the brand’s global presence as a result of international cooperation.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
The offering client seeks experienced distribution companies, of SME to large, multi-national size, from most partner countries (with the exception of Spain, New Zealand, and USA) to engage in a distribution service agreement.
Prospective partners are expected to have extensive knowledge and routes into various local, national, and/or international retail markets. Target markets include end-user retail, wholesale retail, and other retail sector organisations.
Potential partners are required to indicate potential annual volume capabilities, as minimum order quantities would need to be adhered to as set by the offering company.
The client is open to a non-exclusive trial period of 6 months in order to assess a potential distributing partner’s monthly performance. If performance criteria are met, the client hopes to engage in a long-term partnership whereby, the distributing partner would benefit from an exclusive contract for that market/region.
Technical Specification or Expertise Sought:
Ideal distributing partners will understand the science behind the antiviral face covering, know how to position it within local markets as well as, provide competitive analyses and identify new distribution opportunities for the product. Partners are also expected to adhere to the offering client’s packaging/labelling requirements.
Prospective partners must be legally competent and have a strong understanding of the regulations related to distributing a reusable, antiviral face covering/snood. Distributors should also have knowledge in tax and duty charges which may apple to foreign providers of the face covering.
Stage of Development:
Already on the market
IPR Status:
Secret Know-how,Patent(s) applied for but not yet granted,Trade Marks,Exclusive Rights,Copyright
Comments Regarding IPR Status:
Unique protein coating has been trademarked following ISO18184:2019 approval of its protective antiviral capability.
Patent for the face covering has been filed for at the UK Intellectual Property Office.
US Patent has been granted.
External code:
BOUK20201102002
